16 Results

People

  1. Old
    Old
  2. Gnjatic
    Gnjatic
  3. Ritter
    Ritter
  4. Ritter
    Ritter
  5. Allison
    Allison
  6. Atanackovic
    Atanackovic
  7. Jungbluth
    Jungbluth
  8. Matsuo
    Matsuo
  9. Bajorin
    Bajorin
  10. Brennan
    Brennan

Groups

  1. Sloan Kettering Institute Postdocs (6)
  2. GSK Faculty (4)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  4. Department of Medicine (3)
  5. Sloan Kettering Institute Faculty (3)
  6. Solid Tumor Oncology Division (3)
  7. Center for Pancreatic Cancer Research (2)
  8. Genitourinary Oncology Service (2)
  9. Surgery (2)
  10. Advanced Practice Providers (1)
  1. "cancer patient"
  2. "National Academy of Sciences"
Formats
  1. Journal Article (16)
Groups
  1. Sloan Kettering Institute Postdocs (6)
  2. GSK Faculty (4)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  4. Department of Medicine (3)
  5. Sloan Kettering Institute Faculty (3)
  6. Solid Tumor Oncology Division (3)

More Groups

People
  1. Lloyd Old (7)
  2. Sacha Gnjatic (6)
  3. Gerd Ritter (5)
  4. Achim Jungbluth (3)
  5. Erika Ritter (3)
  6. Djordje Atanackovic (2)

More People

Years
  1. 2019 (1)
  2. 2013 (2)
  3. 2012 (1)
  4. 2010 (1)
  5. 2009 (2)
  6. 2008 (4)

More Years

Publications
  1. Proceedings of the National Academy of Sciences of the United States of America (16)
Publishers
  1. National Academy of Sciences (16)

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
    Journal Article

    Wei, S. C.; Anang, N. A. A. S.; Sharma, R.; Andrews, M. C.; Reuben, A.; Levine, J. H.; Cogdill, A. P.; Mancuso, J. J.; Wargo, J. A.; Pe’er, D.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2019)

    Fulltext@MSK | Save
  • Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins
    Journal Article

    Davare, M. A.; Saborowski, A.; Eide, C. A.; Tognon, C.; Smith, R. L.; Elferich, J.; Agarwal, A.; Tyner, J. W.; Shinde, U. P.; Lowe, S. W.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save
  • Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
    Journal Article

    Pang, W. W.; Pluvinage, J. V.; Price, E. A.; Sridhar, K.; Arber, D. A.; Greenberg, P. L.; Schrier, S. L.; Park, C. Y.; Weissman, I. L.
    Proceedings of the National Academy of Sciences of the United States of America (2013)

    Fulltext@MSK | Save
  • Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1
    Journal Article

    Beverly, L. J.; Lockwood, W. W.; Shah, P. P.; Erdjument-Bromage, H.; Varmus, H.
    Proceedings of the National Academy of Sciences of the United States of America (2012)

    Fulltext@MSK | Save
  • Seromic profiling of ovarian and pancreatic cancer
    Journal Article

    Gnjatic, S.; Ritter, E.; Büchler, M. W.; Giese, N. A.; Brors, B.; Frei, C.; Murray, A.; Halama, N.; Zörnig, I.; Chen, Y. T.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2010)

    Fulltext@MSK | Save
  • The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers
    Journal Article

    Veeriah, S.; Brennan, C.; Meng, S.; Singh, B.; Fagin, J. A.; Solit, D. B.; Paty, P. B.; Rohle, D.; Vivanco, I.; Chmielecki, J.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • Anti-CTLA-4 therapy results in higher CD4(+)ICOS(hi) T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
    Journal Article

    Chen, H.; Liakou, C. I.; Kamat, A.; Pettaway, C.; Ward, J. F.; Tang, D. N.; Sun, J.; Jungbluth, A. A.; Troncoso, P.; Logothetis, C.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2009)

    Fulltext@MSK | Save
  • CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
    Journal Article

    Yuan, J.; Gnjatic, S.; Li, H.; Powel, S.; Gallardo, H. F.; Ritter, E.; Ku, G. Y.; Jungbluth, A. A.; Segal, N. H.; Rasalan, T. S.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save
  • Genome-wide analysis of cancer/testis gene expression
    Journal Article

    Hofmann, O.; Caballero, O. L.; Stevenson, B. J.; Chen, Y. T.; Cohen, T.; Chua, R.; Maher, C. A.; Panji, S.; Schaefer, U.; Kruger, A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save
  • Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
    Journal Article

    Hodi, F. S.; Butler, M.; Oble, D. A.; Seiden, M. V.; Haluska, F. G.; Kruse, A.; MacRae, S.; Nelson, M.; Canning, C.; Lowy, I.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2008)

    Fulltext@MSK | Save